IE38604B1 - Prostaglandin compositions - Google Patents

Prostaglandin compositions

Info

Publication number
IE38604B1
IE38604B1 IE218673A IE218673A IE38604B1 IE 38604 B1 IE38604 B1 IE 38604B1 IE 218673 A IE218673 A IE 218673A IE 218673 A IE218673 A IE 218673A IE 38604 B1 IE38604 B1 IE 38604B1
Authority
IE
Ireland
Prior art keywords
carbohydrate
oil
prostaglandin
analogues
sucrose
Prior art date
Application number
IE218673A
Other versions
IE38604L (en
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP47121754A external-priority patent/JPS4980224A/ja
Priority claimed from JP4439473A external-priority patent/JPS558963B2/ja
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of IE38604L publication Critical patent/IE38604L/en
Publication of IE38604B1 publication Critical patent/IE38604B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1424843 Compositions containing prostaglandins ONO PHARMACEUTICAL CO Ltd 4 Dec 1973 [5 Dec 1972 18 April 1973] 56041/ 73 Heading A5B Aerosols suitable for inhalation by human subjects comprise a prostaglandin selected from prostoglandins and analogues and derivatives thereof, as defined, cyclodextrin clathrates of such compounds and non-toxic salts of prostaglandins and analogues thereof, and a pharmaceutically-acceptable liquid medium suitable for oral administration, in association with a carbohydrate selected from sucrose, fructose, maltose, glucose, xylose, mannose, xylitol and mannitol and optionally cinnaman oil or peppermint oil. Liquid compositions comprise a prostaglandin, a medium and a carbohydrate as defined above except that cinnamon oil or peppermint oil are necessarily present when sucrose is the carbohydrate. [GB1424843A]
IE218673A 1972-12-05 1973-12-04 Prostaglandin compositions IE38604B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP47121754A JPS4980224A (en) 1972-12-05 1972-12-05
JP4439473A JPS558963B2 (en) 1973-04-18 1973-04-18

Publications (2)

Publication Number Publication Date
IE38604L IE38604L (en) 1974-06-05
IE38604B1 true IE38604B1 (en) 1978-04-26

Family

ID=26384292

Family Applications (1)

Application Number Title Priority Date Filing Date
IE218673A IE38604B1 (en) 1972-12-05 1973-12-04 Prostaglandin compositions

Country Status (6)

Country Link
AU (1) AU6322173A (en)
DE (1) DE2360414A1 (en)
FR (1) FR2278322A1 (en)
GB (1) GB1424843A (en)
IE (1) IE38604B1 (en)
NL (1) NL7316612A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88490B (en) * 1987-09-14 1992-11-30 Novo Nordisk As PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TRANSOUCIDATING NON-ENTERPRISE LIBERATION CONTAINING MONOSCARARIDOS OR OLIGOSACARIDOS
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
US6054143A (en) * 1998-03-24 2000-04-25 Jones; Alonzo H. Xylitol delivery

Also Published As

Publication number Publication date
IE38604L (en) 1974-06-05
FR2278322A1 (en) 1976-02-13
GB1424843A (en) 1976-02-11
AU6322173A (en) 1975-06-05
DE2360414A1 (en) 1974-06-06
NL7316612A (en) 1974-06-07

Similar Documents

Publication Publication Date Title
IE35326B1 (en) Clathrate prostaglandins and compositions containing same
EP0379147A3 (en) Extrudable elastic gel for use as carrier for therapeutic agent
GB1376096A (en) 1-3,4-methylenedioxy-phenyl-4,4-dimethyl-1-pentene derivatives
IE40361L (en) Bismuth containing pharmaceutical compositions
KR930019203A (en) Megestrol Acetate Formulation
GB1311060A (en) Composition for the amelioration of malodours
IE38604B1 (en) Prostaglandin compositions
GB1450960A (en) Stabilization of prostaglandins
IE36510L (en) Anti-seborrhoeic compositions
DE68900152D1 (en) ACIDYLCYSTONE-CONTAINING SOLID, WATER-SOLUBLE MEDICINAL PRODUCT.
IE38028L (en) Compositions having a physiological cooling effect
JPS55157513A (en) Plasma expander
IE34812B1 (en) Evomonoside derivatives
GB1235599A (en) Lincomycin phosphate derivatives and pharmaceutical compositions containing them
AU501631B2 (en) Non-cariogenic sorbito / xylitol sweetener
CA1004983A (en) Dentifrice containing xylitol as a humectant sweetener
SE7901203L (en) O-SUBSTITUTED OXIMIDE DERIVATIVES OF 7-AMINO-THIAZOLYL-ACETAMIDO-CEPHALOSPORANIC ACID, KIT FOR THE MANUFACTURE AND USE OF THEREOF AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE
SE7705473L (en) PROCEDURE FOR THE PREPARATION OF NAFTYL DERIVATIVES
GB1508338A (en) Pharmaceutical compositions
JPS5340742A (en) Prostagilandin analogues, their preparation and medical composition containing the same as active constituents
GB1380199A (en) Caryophyllene flavouring agents for tobacco
BE808207A (en) Prostaglandin aerosols - which are non-irritant to the upper respiratory tract
AU456733B2 (en) Pharmaceutical compositions containing benzofuran derivatives
IE37718B1 (en) Pharmaceutical compositions
IE780530L (en) Anti-histamine salts and compositions